Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/11/2019
SIETES contiene 92833 citas

 
 
 1 a 20 de 66 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Mayor S. Pregabalin and gabapentin become controlled drugs to cut deaths from misuse. BMJ 2018;363:16 de octubre. [Ref.ID 102878]
2.Enlace a cita original Cita con resumen
Throckmorton DC, Gottlieb S, Woodcock J. The FDA and the next wave of drug abuse — Proactive pharmacovigilance. N Engl J Med 2018;379:19 de julio. [Ref.ID 102679]
3. Cita con resumen
Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National survey on drug use and health. Ann Intern Med 2017;167:293-301. [Ref.ID 102021]
4.Tiene citas relacionadas Cita con resumen
5.Tiene citas relacionadas Cita con resumen
Smith RV, Havens JR, Walsh SL. Gabapentin misuse, abuse and diversion: a systematic review. Addiction 2016;111:1160-74. [Ref.ID 100800]
6.Enlace a cita original
Volkow ND, McLellan AT. Opioid abuse in chronic pain — Misconceptions and mitigation strategies. N Engl J Med 2016;374:1253-63. [Ref.ID 100169]
7.Enlace a cita original Cita con resumen
Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, Dana T, Bougatsos C, Deyo RA. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a national institutes of health pathways to prevention workshop. Ann Intern Med 2015;162:276-86. [Ref.ID 98800]
8. Cita con resumen
Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, Green JL. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med 2015;372:241-8. [Ref.ID 98735]
9. Cita con resumen
Kuehn BM. AHRQ: little evidence for opioids in managing long-term chronic pain. JAMA 2014;312:1185. [Ref.ID 98083]
10. Cita con resumen
Herman AO. Hydrocodone products to get more severe, schedule II classification. Journal Watch 2014:22 de agosto. [Ref.ID 97860]
11.Enlace a cita original Cita con resumen
Kirschner N, Ginsburg J, Snyder Sulmasy L, for the Health and Public Policy Committee of the American College of Physicians. Prescription drug abuse: executive summary of a policy position paper from the American College of Physicians. Ann Intern Med 2014;160:198-200. [Ref.ID 97284]
12.Enlace a cita original Cita con resumen
Young K. Groups ask FDA to keep Zohydro ER hydrocodone off the market. Physician's First Watch 2014:27 de febrero. [Ref.ID 97195]
13. Cita con resumen
Grosshans M, Lemenager T, Vollmert C, Kaemmerer N, Schreiner R, Mutschler J, Wagner X, Kiefer F, Hermann D. Pregabalin abuse among opiate addicted patients. Eur J Clin Pharmacol 2013;69:2021-5. [Ref.ID 96638]
14. Cita con resumen
Anónimo. Néfopam: un bilan français. Prescrire 2013;33:825. [Ref.ID 96494]
15. Cita con resumen
Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A characterization of synthetic cannabinoid exposures reported to the national poison data system in 2010. Ann Emerg Med 2012;60:435-8. [Ref.ID 93146]
16. Cita con resumen
Anónimo. Méthylphénidate: abus et dépendances. Prescrire 2012;32:428. [Ref.ID 93120]
17.
Nelson PK, Mathers BM, Cowie B, Hagan H, Jarlais DD, Horyniak D, Degenhardt L. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 2011;378:571-83. [Ref.ID 91427]
18.Enlace a cita original Cita con resumen
Eaton DK, Kann L, Kinchen S, Shanklin S, Ross J, Hawkins J, Harris WA, Lowry R, McManus T, Chyen D, Lim C, Whittle L, Brener ND, Wechsler H. Youth risk behavior surveillance - United States, 2009. MMWR Morb Mortal Wkly Rep 2010;59:1-142. [Ref.ID 88595]
19.
Anónimo. Hypertension artérielle: et si c'etait l'alcool?. Prescrire 2010;30:446-7. [Ref.ID 88573]
20. Cita con resumen
Schneider MF, Bailey JE, Cicero TJ, Dart RC, Inciardi JA, Parrino M, Muñoz A. Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007. Pharmacoepidemiol Drug Saf 2009;18:778-90. [Ref.ID 86559]
Seleccionar todas
 
 1 a 20 de 66 siguiente >>